Indianapolis-based Beckman Coulter Life Sciences announced it is the first United States distributor of the Genedrive 96 SARS-CoV-2 kit. The agreement with the near-patient molecular diagnostics company, Genedrive, Manchester, UK, is for distribution of the covid-19 kit in the United States and throughout Europe.
The Genedrive 96 SARS-CoV-2 kit is a simple, one-step RT-PCR test to detect SARS-CoV-2 RNA. It offers lyophilized reagents that enable product stability and allow for ambient shipping and storage. The easy-to-set-up assay can streamline laboratory workflows, increase overall throughput, and decrease potential errors for assay set-up. The Genedrive 96 SARS-CoV-2 kit has received the CE-IVD mark and is currently under FDA review for emergency use authorization (EUA).
“Even as vaccines are being administered there is still a critical need to continue covid-19 testing,” says Greg Milosevich, president, Beckman Coulter Life Sciences. “This collaboration provides a turnkey solution for specialized laboratories looking to establish new or expanded test capacity with consumables and labor cost reduction. The ability to streamline the workflow by simultaneously preparing sample extraction and downstream assay set up is a critical step forward in advancing covid testing workflows, increasing throughput and reducing consumables usage.”
To learn more about the partnership or order kits, visit Beckman Coulter Life Sciences.
Featured image: Genedrive 96 SARS-CoV-2 kit (Courtesy: Beckman Coulter Life Sciences)
